Annovis Bio, Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Maria Maccecchini, President and CEO (serving as Interim Principal Financial Officer), certified the June 30, 2026 Form 10-Q on August 14, 2026 under SOX 302 and 906. She attests that disclosure controls and internal controls over financial reporting are effective, financial statements fairly present the company's condition, and no material weaknesses or undisclosed fraud involving management were identified. The certification is a routine executive attestation required by securities law.
Why this rating
Boilerplate SOX certification; no new material facts disclosed. Routine quarterly filing requirement; no operational, financial, or strategic content disclosed in excerpt.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.